BNP Paribas Financial Markets
INFU icon

BNP Paribas Financial Markets’s InfuSystem Holdings INFU Stock Holding History

BNP Paribas Financial Markets’s Portfolio INFU Stock Details INFU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$476K Sell
49,309
-61,289
-55% -$581K ﹤0.01% 3794
2026
Q1 		$1.02M Buy
110,598
+19,377
+21% +$169K ﹤0.01% 3125
2025
Q4 		$818K Buy
91,221
+63,313
+227% +$606K ﹤0.01% 3251
2025
Q3 		$289K Buy
27,908
+24,476
+713% +$203K ﹤0.01% 3834
2025
Q2 		$21.4K Sell
3,432
-21,223
-86% -$117K ﹤0.01% 4571
2025
Q1 		$133K Buy
24,655
+17,811
+260% +$130K ﹤0.01% 3927
2024
Q4 		$57.8K Buy
6,844
+2,768
+68% +$21.8K ﹤0.01% 4372
2024
Q3 		$27.3K Buy
4,076
+1,626
+66% +$10.5K ﹤0.01% 3715
2024
Q2 		$16.7K Sell
2,450
-6,202
-72% -$45.6K ﹤0.01% 3659
2024
Q1 		$74.1K Sell
8,652
-474
-5% -$4.45K ﹤0.01% 3505
2023
Q4 		$96.2K Sell
9,126
-11,453
-56% -$112K ﹤0.01% 3407
2023
Q3 		$198K Buy
20,579
+15,745
+326% +$161K ﹤0.01% 3094
2023
Q2 		$46.6K Buy
4,834
+4,713
+3,895% +$42.7K ﹤0.01% 3493
2023
Q1 		$938 Sell
121
-49
-29% -$451 ﹤0.01% 3688
2022
Q4 		$1.48K Sell
170
-810
-83% -$6.6K ﹤0.01% 3763
2022
Q3 		$6.85K Sell
980
-686
-41% -$5.75K ﹤0.01% 4219
2022
Q2 		$16K Sell
1,666
-81
-5% -$709 ﹤0.01% 3707
2022
Q1 		$17.1K Sell
1,747
-2,310
-57% -$29.7K ﹤0.01% 3745
2021
Q4 		$69.1K Buy
4,057
+679
+20% +$10.8K ﹤0.01% 3682
2021
Q3 		$44K Buy
3,378
+2,732
+423% +$44.6K ﹤0.01% 3548
2021
Q2 		$13.4K Sell
646
-1,209
-65% -$24.4K ﹤0.01% 3649
2021
Q1 		$37.8K Sell
1,855
-889
-32% -$16.7K ﹤0.01% 3673
2020
Q4 		$51.5K Sell
2,744
-607
-18% -$9.14K ﹤0.01% 3541
2020
Q3 		$43K Buy
3,351
+2,809
+518% +$36.5K ﹤0.01% 3540
2020
Q2 		$6.25K Buy
+542
New +$6.23K ﹤0.01% 3909
2014
Q3 		– Sell
-268
Closed -$710 – 4190
2014
Q2 		$710 Hold
268
– – ﹤0.01% 3520
2014
Q1 		$756 Hold
268
– – ﹤0.01% 2942
2013
Q4 		$574 Buy
+268
New +$469 ﹤0.01% 3920

Other funds holding INFU

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MA
Minerva Advisors Bala Cynwyd, Pennsylvania $158M AUM 42.05% 1-Year Est. Return
PAIM
Punch & Associates Investment Management Edina, Minnesota $2.02B AUM 40.6% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $2.25B AUM 44.61% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BNP Paribas Financial Markets's INFU Position: Q2 2026 in Review

BNP Paribas Financial Markets reduced its InfuSystem Holdings (INFU) stake by 55% in Q2 2026, selling an estimated $581K and leaving 49,309 shares worth $476K. The position accounts for ﹤0.01% of the portfolio, ranked #3794.

BNP Paribas Financial Markets first reported a position in INFU in Q4 2013 and has held it in 28 quarters since. The position peaked at $1.02M in Q1 2026. 100 funds tracked by Wall St. Rank hold INFU as of Q2 2026.

  • BNP Paribas Financial Markets held 49,309 shares of InfuSystem Holdings worth $476K as of Q2 2026.
  • BNP Paribas Financial Markets sold 61,289 InfuSystem Holdings shares in Q2 2026, an estimated $581K.
  • InfuSystem Holdings made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #3794 holding.
  • BNP Paribas Financial Markets first reported a position in InfuSystem Holdings in Q4 2013 and has held it in 28 quarters since.
  • BNP Paribas Financial Markets's InfuSystem Holdings position peaked at $1.02M in Q1 2026.
  • 100 funds tracked by Wall St. Rank held InfuSystem Holdings as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.